Home/Filings/4/0000950170-24-005531
4//SEC Filing

Jordan Julie 4

Accession 0000950170-24-005531

CIK 0001404644other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:48 PM ET

Size

5.7 KB

Accession

0000950170-24-005531

Insider Transaction Report

Form 4
Period: 2024-01-16
Jordan Julie
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-16+75,00075,000 total
    Exercise: $32.30Exp: 2034-01-16Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option represents the right to purchase 75,000 shares of common stock of the Issuer, of which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments through January 16, 2028, subject to the reporting person's continued service to the Issuer through each applicable vesting date.

Documents

1 file

Issuer

Neurogene Inc.

CIK 0001404644

Entity typeother

Related Parties

1
  • filerCIK 0001968554

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:48 PM ET
Size
5.7 KB